BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1449 related articles for article (PubMed ID: 18815746)

  • 1. Novel alpha-KTx sites in the BK channel and comparative sequence analysis reveal distinguishing features of the BK and KV channel outer pore.
    Giangiacomo KM; Becker J; Garsky C; Schmalhofer W; Garcia ML; Mullmann TJ
    Cell Biochem Biophys; 2008; 52(1):47-58. PubMed ID: 18815746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
    Jäger H; Grissmer S
    Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A set of homology models of pore loop domain of six eukaryotic voltage-gated potassium channels Kv1.1-Kv1.6.
    Liu HL; Lin JC
    Proteins; 2004 May; 55(3):558-67. PubMed ID: 15103620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of alpha-KTx specificity.
    Giangiacomo KM; Ceralde Y; Mullmann TJ
    Toxicon; 2004 Jun; 43(8):877-86. PubMed ID: 15208020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accessory Kvbeta1 subunits differentially modulate the functional expression of voltage-gated K+ channels in mouse ventricular myocytes.
    Aimond F; Kwak SP; Rhodes KJ; Nerbonne JM
    Circ Res; 2005 Mar; 96(4):451-8. PubMed ID: 15662035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
    Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
    Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-dependent block of BK channels by synthesized shaker ball peptides.
    Li W; Aldrich RW
    J Gen Physiol; 2006 Oct; 128(4):423-41. PubMed ID: 16966472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels.
    Decher N; Kumar P; Gonzalez T; Renigunta V; Sanguinetti MC
    Mol Pharmacol; 2005 Oct; 68(4):995-1005. PubMed ID: 16024663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Information of charybdotoxin blockade in the large conductance calcium-activated potassium channel.
    Qiu S; Yi H; Liu H; Cao Z; Wu Y; Li W
    J Chem Inf Model; 2009 Jul; 49(7):1831-8. PubMed ID: 19499912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits.
    Mourre C; Chernova MN; Martin-Eauclaire MF; Bessone R; Jacquet G; Gola M; Alper SL; Crest M
    J Pharmacol Exp Ther; 1999 Dec; 291(3):943-52. PubMed ID: 10565809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel alpha-KTx peptides from the venom of the scorpion Centruroides elegans selectively blockade Kv1.3 over IKCa1 K+ channels of T cells.
    Olamendi-Portugal T; Somodi S; Fernández JA; Zamudio FZ; Becerril B; Varga Z; Panyi G; Gáspár R; Possani LD
    Toxicon; 2005 Sep; 46(4):418-29. PubMed ID: 16026809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved gating hinge in ligand- and voltage-dependent K+ channels.
    Magidovich E; Yifrach O
    Biochemistry; 2004 Oct; 43(42):13242-7. PubMed ID: 15491131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels.
    Mouhat S; Mosbah A; Visan V; Wulff H; Delepierre M; Darbon H; Grissmer S; De Waard M; Sabatier JM
    Biochem J; 2004 Jan; 377(Pt 1):25-36. PubMed ID: 12962541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution structure of maurotoxin, a scorpion toxin from Scorpio maurus, with high affinity for voltage-gated potassium channels.
    Blanc E; Sabatier JM; Kharrat R; Meunier S; el Ayeb M; Van Rietschoten J; Darbon H
    Proteins; 1997 Nov; 29(3):321-33. PubMed ID: 9365987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of maurotoxin binding sites on hKv1.2, hKv1.3, and hIKCa1 channels.
    Visan V; Fajloun Z; Sabatier JM; Grissmer S
    Mol Pharmacol; 2004 Nov; 66(5):1103-12. PubMed ID: 15286210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beta 1 subunit of L-type voltage-gated Ca2+ channels independently binds to and inhibits the gating of large-conductance Ca2+-activated K+ channels.
    Zou S; Jha S; Kim EY; Dryer SE
    Mol Pharmacol; 2008 Feb; 73(2):369-78. PubMed ID: 17989350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different residues in channel turret determining the selectivity of ADWX-1 inhibitor peptide between Kv1.1 and Kv1.3 channels.
    Yin SJ; Jiang L; Yi H; Han S; Yang DW; Liu ML; Liu H; Cao ZJ; Wu YL; Li WX
    J Proteome Res; 2008 Nov; 7(11):4890-7. PubMed ID: 18937510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of d-tubocurarine with potassium channels: molecular modeling and ligand binding.
    Rossokhin A; Teodorescu G; Grissmer S; Zhorov BS
    Mol Pharmacol; 2006 Apr; 69(4):1356-65. PubMed ID: 16391240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evolutionarily conserved binding site for serine proteinase inhibitors in large conductance calcium-activated potassium channels.
    Moss GW; Marshall J; Morabito M; Howe JR; Moczydlowski E
    Biochemistry; 1996 Dec; 35(50):16024-35. PubMed ID: 8973172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
    Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
    Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.